Diagnosing and Treating Infant Botulism
Since the approval of BabyBIG, the only treatment for this rare but life-threatening disease affecting infants mostly under 6 months, the mortality rate is now less than 15 percent.
Update on Rabies
Though mostly eradicated in the U.S., treatment for rabies must begin immediately with hyperimmune globulin and vaccines.
New and Better Hemophilia A Treatment Options Just Keep Coming
With 16 FVIII products now approved for the treatment of hemophilia A, many patients with this disease are now able to live a normal life.
Diagnosing and Treating Lyme Disease
Lyme disease is a rare disease that can cause long-term damage thanks to delayed and missed diagnoses — but it may soon have a vaccine.
Myths & Facts: Kawasaki Disease
Educating physicians about this not-so-rare disease can curtail lifelong consequences that can occur if not diagnosed and treated early.
In the R&D Pipeline: New Agents to Prevent and Treat Hereditary Angioedema Attacks
A number of promising new agents in the R&D pipeline are likely to be approved in the very near future, expanding an already impressive range of treatment options — while further increasing the complexity of the HAE management decision process.
The Expanding Role of Immune Globulin Treatment in Diseases: Utilization and Growth
New research showing the therapeutic benefit of immune globulin for treating a variety of autoimmune diseases is contributing to market growth of this essential medicine.
ChatGPT: Optimizing Patient Care
The accomplishments of AI in the healthcare sector are impressive, but as AI continues to improve patient care and enhance provider skills, addressing its challenges will be critical.
Myths & Facts: Prenatal Care
With almost a quarter of women receiving inadequate prenatal care in the U.S., more needs to be done to inform women about the myths surrounding this essential healthcare service.
New Gene Therapies Are Transformative for People with Sickle Cell Disease and Frequent Vaso-Occlusive Crises
Affecting more than 100,000 American children and adults, sickle cell disease is an inherited hemoglobinopathy that results when a single-nucleotide mutation in the ß-globin gene yields an abnormal “sickle” hemoglobin (HbS). Now, these patients may be eligible for a one-time gene therapy that offers the potential of a durable functional cure by eliminating severe VOCs and associated hospitalizations.
